Coraopolis, PA, United States of America

Nick Giannoukakis

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • Pittsburgh, PA (US) (2005)
  • Coraopolis, PA (US) (2011 - 2021)

Company Filing History:


Years Active: 2005-2021

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations by Nick Giannoukakis: Pioneering Autoimmune Therapies

Introduction

Nick Giannoukakis is a distinguished inventor based in Coraopolis, PA, who has contributed significantly to the field of autoimmune therapies. With a total of nine patents to his name, Giannoukakis has demonstrated a strong commitment to advancing medical science through his inventive solutions.

Latest Patents

One of his latest patents focuses on "Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoimmune therapies." This innovative invention relates to the development of tolerogenic mammalian dendritic cells (iDCs) and outlines methods for producing these crucial cells. Furthermore, the patent provides techniques for the administration of tolerogenic dendritic cells, along with particles containing oligonucleotides, to mammalian subjects. The enhanced tolerogenicity in a host can be particularly useful for treating inflammatory and autoimmune-related diseases, such as type 1 diabetes.

Career Highlights

Throughout his career, Giannoukakis has made notable contributions while working with prominent organizations, such as the University of Pittsburgh and Baxter International Inc. His work has not only advanced scientific understanding but has also opened new avenues for effective treatments in autoimmune disease management.

Collaborations

Giannoukakis has collaborated with esteemed colleagues, including Massimo M. Trucco and Larry Richard Brown. These partnerships have further enriched his research and invention pursuits, leading to innovative developments that improve patient outcomes in the realm of autoimmune therapies.

Conclusion

Nick Giannoukakis stands out as a prominent inventor in the field of autoimmune therapy research. His innovative patents and collaborations demonstrate a relentless pursuit of knowledge and advancement in medical technology. As he continues to develop groundbreaking solutions, his work promises to have a lasting impact on the treatment of autoimmune diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…